ANTICHOLIUM

This brand name is authorized in Austria, Estonia

Active ingredients

The drug ANTICHOLIUM contains one active pharmaceutical ingredient (API):

1 Physostigmine UNII 2046ZRO9VU - PHYSOSTIGMINE SALICYLATE

Physostigmine is a reversible inhibitor of acetylcholinesterase. As an inhibitor of acetyl-cholinesterase, physostigmine slows down the degradation of acetylcholine and acts like an indirect parasympathomimetic drug due to an increase of the acetylcholine concentration at the receptor. Read about Physostigmine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ANTICHOLIUM Injection solution		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EB05	Physostigmine	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB05
V03AB19	Physostigmine	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1140130